Discover how LPS activates immune cells through NOX4 and Giα-dependent PI3K signaling, driving inflammatory responses in human PBMCs.
Breakthrough research on IL-7 receptor blockade as a targeted therapy for ulcerative colitis, featuring clinical trial results and mechanistic insights.